UK Top 10 News

Stay informed with the latest breaking news from across the UK

A price hike for the popular weight-loss drug Mounjaro has raised concerns about its affordability for users in the UK.
The drug, which works by making users feel full, has about 1.5 million users in the country.
The price increase, which was announced to pharmacies weeks ago, has already been factored into their planned price increases.
Olivier Picard, chairman of the National Pharmacy Association, stated that 'Prices advertised in many pharmacies will already reflect this discount and pharmacies will also have to wait to receive this retrospectively after dispensing.' He added that pharmacies are working to 'explore if there are options to minimise disruption to their treatment programme.' The majority of Mounjaro users get the drug privately from pharmacies as part of weight-loss programs.
This is why the price increase has caused significant concern among users, many of whom are worried they will not be able to afford the drug.
Mounjaro is a rival to another weight-loss drug, Wegovy.
The drugs' mechanism of action is similar, and they have both gained popularity for their effectiveness in helping people lose weight.
The situation highlights the challenges of accessing expensive weight-loss medications, particularly for those who rely on private prescriptions.
The lack of a clear, immediate discount has left many users feeling uncertain about their ability to continue their treatment.
The National Pharmacy Association's efforts to mitigate the impact of the price hike are a sign of the widespread concern about the issue.




showbiz sport money travel garden news tech health science politics culture business environment